A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma Meeting Abstract
| Authors: | Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; Grisham, R. N.; Kyi, C.; Soldan, K.; Lichtman, S. M.; Ligresti, L.; Schweber, S. J.; Singh, J. C.; Troso-Sandoval, T. A.; Aghajanian, C.; Makker, V. |
| Abstract Title: | A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 334s |
| Language: | English |
| ACCESSION: | WOS:000487345805573 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.5582 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5582 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work